EYPT

EYPT

USD

EyePoint Pharmaceuticals Inc. Common Stock

$9.720-0.010 (-0.103%)

即時價格

Healthcare
生物科技
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$9.730

最高

$10.020

最低

$9.630

交易量

0.33M

公司基本面

市值

668.8M

行業

生物科技

國家

United States

交易統計

平均交易量

0.83M

交易所

NGM

貨幣

USD

52週範圍

最低 $3.91當前 $9.720最高 $13.99

相關新聞

GlobeNewswire

EyePoint Announces Participation at Upcoming Investor Conferences

WATERTOWN, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with

查看更多
EyePoint Announces Participation at Upcoming Investor Conferences
GlobeNewswire

EyePoint Completes Enrollment in Pivotal Phase 3 LUGANO Trial of DURAVYU™ for Treatment of Wet Age-Related Macular Degeneration

– Over 400 patients enrolled and randomized over a seven-month period, driven by strong physician and patient interest – – LUCIA pivotal Phase 3 trial continues rapid enrollment pace with 60% of patients randomized;

查看更多
EyePoint Completes Enrollment in Pivotal Phase 3 LUGANO Trial of DURAVYU™ for Treatment of Wet Age-Related Macular Degeneration
Analyst Upgrades

Mizuho Maintains Outperform on EyePoint Pharmaceuticals, Lowers Price Target to $26

Mizuho analyst Graig Suvannavejh maintains EyePoint Pharmaceuticals with a Outperform and lowers the price target from $30 to $26.

查看更多
Mizuho Maintains Outperform on EyePoint Pharmaceuticals, Lowers Price Target to $26
GlobeNewswire

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

WATERTOWN, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious

查看更多
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)